Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment

Acuitas Therapeutics Expands Collaboration with RNA Technologies & Therapeutics Through Strategic Investment

VANCOUVER, British Columbia -- Acuitas Therapeutics, the global leader in lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, today announced that it has acquired a majority stake in RNA Technologies & Therapeutics (RNA T&T), a company specializing in the design, optimization and manufacture of high-quality RNA constructs. This investment will support the growth and development of RNA T&T, allowing it to further develop and …